SCHEMBL10089552

SCHEMBL10089552

INc1nncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837389 0.66
SCHEMBL10467309 0.66
SCHEMBL12763781 0.64 CYP1A2 (0.61)
SCHEMBL11623839 0.63 TAAR1 (0.60)
SCHEMBL6698873 0.63 CYP1A2 (0.59)
SCHEMBL12599389 0.62 NR3C1 (0.53)
SCHEMBL18469863 0.56
SCHEMBL11119985 0.56
SCHEMBL22144340 0.54
SCHEMBL8019114 0.34

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2945943-B1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-30 EP disclosed
WO-2012085815-A1 BI-HETEROARYL COMPOUNDS AS VPS34 INHIBITORS NOVARTIS AG (CH) 2012-06-28 WO disclosed